0001565847-15-000002.txt : 20150825 0001565847-15-000002.hdr.sgml : 20150825 20150825172433 ACCESSION NUMBER: 0001565847-15-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150825 DATE AS OF CHANGE: 20150825 EFFECTIVENESS DATE: 20150825 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Benson Hill Biosystems, Inc. CENTRAL INDEX KEY: 0001565847 IRS NUMBER: 455483749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-246433 FILM NUMBER: 151074032 BUSINESS ADDRESS: STREET 1: 100 CAPITOLA DRIVE, SUITE 240 CITY: DURHAM STATE: NC ZIP: 27713-4496 BUSINESS PHONE: 919-313-6636 MAIL ADDRESS: STREET 1: 100 CAPITOLA DRIVE, SUITE 240 CITY: DURHAM STATE: NC ZIP: 27713-4496 D 1 primary_doc.xml X0707 D LIVE 0001565847 Benson Hill Biosystems, Inc. 100 CAPITOLA DRIVE, SUITE 240 DURHAM NC NORTH CAROLINA 27713-4496 919-313-6636 DELAWARE None None Corporation true 2012 Matthew B Crisp 440 WEYCROFT GRANT DRIVE Cary NC NORTH CAROLINA 27519 Executive Officer Director Daniel J Broderick 100 Capitola Drive, Suite 240 Durham NC NORTH CAROLINA 27713-4496 Director Mr. Broderick resigned as a director effective as of the 8-20-2015 initial closing of the offering, and following the 8-20-2015 initial closing of the offering the Board will be reconstituted to include representatives of the new investors Gregg Bogosian 100 Capitola Drive, Suite 240 Durham NC NORTH CAROLINA 27713-4496 Director Mr. Bogosian resigned as a director effective as of the 8-20-2015 initial closing of the offering, and following the 8-20-2015 initial closing of the offering the Board will be reconstituted to include representatives of the new investors Bruce A Jamerson 100 Capitola Drive, Suite 240 Durham NC NORTH CAROLINA 27713-4496 Director Mr. Jamerson resigned as a director effective as of the 8-20-2015 initial closing of the offering, and following the 8-20-2015 initial closing of the offering the Board will be reconstituted to include representatives of the new investors Walter P Siggelko 100 Capitola Drive, Suite 240 Durham NC NORTH CAROLINA 27713-4496 Director Mr. Siggelko resigned as a director effective as of the 8-20-2015 initial closing of the offering, and following the 8-20-2015 initial closing of the offering the Board will be reconstituted to include representatives of the new investors Thomas P Brutnell 100 Capitola Drive, Suite 240 Durham NC NORTH CAROLINA 27713-4496 Executive Officer Todd C Mockler 100 Capitola Drive, Suite 240 Durham NC NORTH CAROLINA 27713-4496 Executive Officer Lee Palles 100 Capitola Drive, Suite 240 Durham NC NORTH CAROLINA 27713-4496 Executive Officer Nadine Carozzi 100 Capitola Drive, Suite 240 Durham NC NORTH CAROLINA 27713-4496 Executive Officer Other Technology Decline to Disclose 06b false 2015-08-20 false true false 50000 None None None None None None None XX Unknown None CA CALIFORNIA DC DISTRICT OF COLUMBIA KS KANSAS MO MISSOURI TX TEXAS false 8500000 7300000 1200000 The above represents cash proceeds from the sale of Series A Preferred stock. In addition to the foregoing, $2,402,432 of existing Convertible Notes were pursuant to their terms automatically converted into shares of Series A Preferred stock. false 10 0 0 0 true false Benson Hill Biosystems, Inc. Matthew B. Crisp Matthew B Crisp President 2015-08-25